UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX)

CUSIP: 91381U200

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
17,209,280
Total 13F shares
2,694,748
Share change
-456,974
Total reported value
$6,871,402
Put/Call ratio
1.8%
Price per share
$2.55
Number of holders
38
Value change
-$979,883
Number of buys
12
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 91381U200?
CUSIP 91381U200 identifies UNBX - UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX) as of Q2 2023

As of 30 Jun 2023, UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,694,748 shares. The largest 10 holders included ARCH Venture Management, LLC, VANGUARD GROUP INC, UBS OCONNOR LLC, GEODE CAPITAL MANAGEMENT, LLC, Mayo Clinic, BlackRock Inc., Laurion Capital Management LP, DIMENSIONAL FUND ADVISORS LP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and Founders Fund V Management, LLC. This page lists 38 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.